CrushSCI.com
Journal Selection & Manuscript Polishing Services
DRUG DEVELOPMENT RESEARCH journal cover Medicine
Back to journal directory

Review Cycle Records

DRUG DEVELOPMENT RESEARCH

Wiley SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q1
143.1Average days
127Median days
19Fastest days
328Longest days
1812025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

40 days

Targeting CDK‐2 With Novel Indole‐Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies

AuthorsWagdy M. Eldehna; Zainab M. Elsayed; Mohamed R. Elnagar; Yasser M. Omar; Maha‐Hamadien Abdulla; Abdulrahman M. Saleh; Abdelrahman R. Shalabi; Diaaeldin M. Elimam; Suliman Alshamari; Mohamed Fares; Haytham O. Tawfik

Affiliations1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Kafrelsheikh University Kafrelsheikh Egypt; 2. Scientific Research and Innovation Support Unit, Faculty of Pharmacy Kafrelsheikh University Kafrelsheikh Egypt; 3. Department of Pharmacology and Toxicology, Faculty of Pharmacy Al‐Azhar University Cairo Egypt; 4. Department of Pharmacology, College of Pharmacy The Islamic University Najaf Iraq; 5. Institute of Cancer Therapeutics University of Bradford Bradford UK; 6. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy Assiut University Assiut Egypt; 7. Colorectal Research Chair, Department of Surgery, College of Medicine King Saud University Riyadh Saudi Arabia; 8. Postgraduate Program in Pharmaceutical Chemistry, Faculty of Pharmacy Cairo University, Cairo University Cairo Egypt; 9. Pharmaceutical Chemistry Department, Faculty of Pharmacy Sinai University North Sinai Egypt; 10. Department of Pharmacognosy, Faculty of Pharmacy Kafrelsheikh University Kafrelsheikh Egypt; 11. Sydney Pharmacy School The University of Sydney Sydney New South Wales Australia; 12. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Tanta University Tanta Egypt; 13. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Alsalam University Tanta Egypt

Source PDF DOI Publisher page
177 days

Alternative Splicing in Cyclin‐Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor‐Positive Breast Cancer

AuthorsYuqiu Cui; Jia Xie; Jiale Cai; Yue Si; Hairong Huang; Shiyi Yu; Haibo Sun

Affiliations1. School of Medicine (Institute of Translational Medicine) Yangzhou University Yangzhou China; 2. Jiangsu Key Laboratory of Noncoding RNA Fundamental and Clinical Translational Research Yangzhou China

Source PDF DOI Publisher page
76 days

Applications of Bioinorganic Nano‐Based Delivery Systems—Diagnostics and Therapeutics

AuthorsFrank Ssengooba; Jubilee Andrew; Donald Fernandes

Affiliations1. Department of Pharmacy Practice, School of Pharmacy Sefako Makgatho Health Sciences University Pretoria South Africa; 2. Department of Pharmaceutical Sciences, School of Pharmacy Sefako Makgatho Health Sciences University Pretoria South Africa; 3. Department of Chemistry and Biology Toronto Metropolitan University Toronto Ontario Canada

Source PDF DOI Publisher page
210 days

GRP78 Drives NSCLC Stemness and EMT via a SIX1/β‐Catenin Signaling Axis

AuthorsGuoping Tong; Huanyu Qi

Affiliations1. Department of Respiratory and Tumor Internal Medicine, Chinese Academy of Medical Sciences Cancer Hospital Shanxi Hospital Shanxi Cancer Hospital Taiyuan City Shanxi Province China; 2. Department of Bone and Soft Tissue Tumor Oncology, Chinese Academy of Medical Sciences Cancer Hospital Shanxi Hospital Shanxi Cancer Hospital Taiyuan City Shanxi Province China

Source PDF DOI Publisher page
294 days

TrxR Inhibition and Nrf2–FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance

AuthorsCharan Singh Pawar; Nagarajan Rajendra Prasad

Affiliations1. Department of Biochemistry and Biotechnology Annamalai University Chidambaram Tamil Nadu India

Source PDF DOI Publisher page
69 days

Two Novel 1,4‐Naphthoquinone Derivatives as Potent Agents Against Multidrug‐Resistant Staphylococcus aureus and Pathogenic Gram‐Positive Bacteria

AuthorsHyunChan Song; Haena Lee; Ji‐Hyun Yoon; Hyunkyung Choi; Hakwon Kim; Ki‐Young Kim

Affiliations1. Graduate School of Biotechnology Kyung Hee University Yongin Republic of Korea; 2. Department of Applied Chemistry, Global Center for Pharmaceutical Ingredient Materials Kyung Hee University Yongin Republic of Korea

Source PDF DOI Publisher page
71 days

Discovery of a Potent and Selective MAO‐B Inhibitor From a Donepezil‐Linked Chalcone Library With Promising Antiparkinsonian Activity

AuthorsAzize Kirac‐Aydin; Bishnu Prasad Pandey; Satyajit Mohanty; Rupsa Mondal; Abanish Biswas; Ashok Kumar Pattnaik; Subodh Mondal; Vinay N. Basavanakatti; Nilüfer Bayrak; Venkatesan Jayaprakash; Hoon Kim; Amaç Fatih TuYuN

Affiliations1. Department of Chemistry, Faculty of Science Istanbul University Istanbul Türkiye; 2. Institute of Graduate Studies in Science Istanbul University Istanbul Türkiye; 3. Department of Pharmacy College of Pharmacy, Sunchon National University Suncheon Republic of Korea; 4. Department of Chemical Science and Engineering Kathmandu University Kavre Nepal; 5. Department of Pharmaceutical Sciences and Technology Birla Institute of Technology Ranchi India; 6. Bioanalysis, Eurofins Advinus Biopharma Services India Pvt. Ltd Bengaluru India; 7. Adgyl Lifesciences Private Limited Bengaluru India

Source PDF DOI Publisher page
55 days

Ameliorative Effects of a Naphthoquinone Derivative With β‐Amyloid Aggregation Inhibitory Activity on Cognitive Impairment and Metabolite Analysis of the Blood and Brains of Mice

AuthorsJong Min Oh; Won Kyeong Jeong; Hyun Ju Son; Seo Young Kim; Tae Woo Oh; Moongi Ji; Ji Woo Nam; Minyeong Baek; Jeong‐Ho Park; Woong‐Hee Shin; Hee Jung Kim; Byeongchan Choi; Man‐Jeong Paik; Hoon Kim

Affiliations1. Department of Pharmacy, College of Pharmacy Sunchon National University Suncheon Republic of Korea; 2. Herbal Medicine Resources Research Center Korea Institute of Oriental Medicine Naju Republic of Korea; 3. Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine (KIOM) Daegu Republic of Korea; 4. University of Science and Technology (UST), Korean Convergence Medicine Major KIOM Daejeon Republic of Korea; 5. Department of Chemical & Biological Engineering Hanbat National University Daejeon Republic of Korea; 6. Department of Biomedical Informatics, College of Medicine Korea University Seoul Republic of Korea

Source PDF DOI Publisher page
106 days

Discovery of Novel PCSK9‐LDLR PPI Inhibitors by a Structural Modification Approach

AuthorsHuan Zhu; Zhiqin Zhang; Lihui Zhang; Jiangying Cao; Lei Zhang

Affiliations1. School of Pharmacy Shandong Second Medical University Weifang Shandong China; 2. School of Stomatology Shandong Second Medical University Weifang Shandong China; 3. School of Pharmacy Shandong University of Traditional Chinese Medicine Jinan Shandong China

Source PDF DOI Publisher page
324 days

A Tale of Two Mechanisms: The p53 Modulator COTI‐2 Is a Zn Metallochaperone

Authorsİrem Şimşek; Farsheed Shahbazi‐Raz; Michael J. Krause; Azam Mohammadzadeh; Maryam Kosar; Peihan Xu; Samra Khan; Olena Tykhoniuk; Ashley DaDalt; Deya'a Almasri; Lara K. Watanabe; Kaitlyn Breault; John J. Hayward; Fraser S. Pick; Richard L. Ho; Jeremy M. Rawson; John F. Trant

Affiliations1. Department of Chemistry and Biochemistry University of Windsor Windsor Ontario Canada; 2. Binary Star Research Services LaSalle Ontario Canada; 3. Department of Biomedical Sciences University of Windsor Windsor Ontario Canada; 4. Amaro Therapeutics New York New York USA; 5. WE‐Spark Research Institute Windsor Ontario Canada

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.